INO:NASDAQ
Inovio Pharmaceuticals Inc
$0.99
arrow_upward
+0.37%(+0.0037) 1D
Oct 19, 11:26:06 AM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for INO...
Open
$1.01
High
$1.02
Low
$0.98
Mkt. cap
102.77M
Avg. vol.
2.87M
Volume
838.40K
52-wk high
$2.72
52-wk low
$0.57
EPS
-$1.17
Beta
1.61
Shares outstanding
103.40M
No. of employees
112
Open
$1.01
High
$1.02
Low
$0.98
Mkt. cap
102.77M
Avg. vol.
2.87M
Volume
838.40K
52-wk high
$2.72
52-wk low
$0.57
EPS
-$1.17
Beta
1.61
Shares outstanding
103.40M
No. of employees
112
News stories
From web sources and news partners
HDFC Sky
·
34 minutes ago
Nasdaq Jumps 259 Points to 26,399 as Intel Surges 5.5% and AI Stocks Rebound After Brutal Selloff
TipRanks
·
27 minutes ago
Dow Jones Steady as AI Stocks Rebound from Selloff
TradingView
·
1 hour ago
The Dow Jones Index Opens 0.08% Lower
Profile
Inovio Pharmaceuticals, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development. Wikipedia
About Inovio Pharmaceuticals Inc